José J. Pérez

3.4k total citations
27 papers, 755 citations indexed

About

José J. Pérez is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, José J. Pérez has authored 27 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 9 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in José J. Pérez's work include Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (8 papers) and Acute Myeloid Leukemia Research (6 papers). José J. Pérez is often cited by papers focused on Chronic Lymphocytic Leukemia Research (8 papers), Multiple Myeloma Research and Treatments (8 papers) and Acute Myeloid Leukemia Research (6 papers). José J. Pérez collaborates with scholars based in Spain, United States and Netherlands. José J. Pérez's co-authors include María‐Belén Vídriales, Jesús F. San Miguel, Alberto Órfão, Norma C. Gutiérrez, Bruno Paiva, Marcos González, Consuelo del Cañizo, Joaquı́n Dı́az-Mediavilla, María José Calmuntia and Fernando Ramos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Chemistry.

In The Last Decade

José J. Pérez

24 papers receiving 736 citations

Peers

Countries citing papers authored by José J. Pérez

Since Specialization

Citations

This map shows the geographic impact of José J. Pérez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José J. Pérez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José J. Pérez more than expected).

Fields of papers citing papers by José J. Pérez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José J. Pérez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José J. Pérez. The network helps show where José J. Pérez may publish in the future.

Co-authorship network of co-authors of José J. Pérez

This figure shows the co-authorship network connecting the top 25 collaborators of José J. Pérez. A scholar is included among the top collaborators of José J. Pérez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José J. Pérez. José J. Pérez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between Access to Alternatives to Daytime In-Center Hemodialysis and Employment among Patients with Kidney Failure 2025 ·Clinical Journal of the American Society of Nephrology ·José J. Pérez, Jingbo Niu, (unknown), Wolfgang C. Winkelmayer, Kerri L. Cavanaugh, Monique R. Pappadis, Kevin F. Erickson	0
2	Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation 2025 ·Molecular Oncology ·(unknown), (unknown), Cristina De Ramón, Elizabeta A. Rojas, Irena Misiewicz-Krzemińska, (unknown), José J. Pérez, (unknown), Noemí Puig, Miguel Alcoceba, María‐Victoria Mateos, Luís A. Corchete, Myriam Cuadrado, Norma C. Gutiérrez	0
3	B-336 Analytical verification of the EXENT® solution for the identification an quantitation of monoclonal immunoglobulins by mass spectrometry 2024 ·Clinical Chemistry ·(unknown), Noemí Puig, (unknown), (unknown), (unknown), Asunción Díaz, José J. Pérez, Jesús F. San Miguel, Juan José Lahuerta, J Bladé, María‐Victoria Mateos	1
4	Clinical Significance of Measurable Residual Disease (MRD) in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Chimeric Antigen Receptor (CAR) T Cells and T-Cell Engagers (TCE) 2023 ·Blood ·Aintzane Zabaleta, Noemí Puig, (unknown), José J. Pérez, Cristina Moreno, (unknown), Paula Rodríguez‐Otero, Verónica González‐Calle, Lucía López‐Corral, (unknown), (unknown), Fátima Mirás, José María Sánchez‐Pina, (unknown), Joaquín Martínez‐López, María‐Victoria Mateos, Jesús F. San Miguel, Bruno Paiva	4
5	Dialysis Modality and Incident Atrial Fibrillation in Older Patients With ESRD 2018 ·American Journal of Kidney Diseases ·Jingbo Niu, Maulin Shah, José J. Pérez, (unknown), Sankar D. Navaneethan, Mintu P. Turakhia, Tara I. Chang, Wolfgang C. Winkelmayer	20
6	DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma 2017 ·Journal of Hematology & Oncology ·Dalia Quwaider, Luís A. Corchete, Irena Misiewicz-Krzemińska, María Eugenia Sarasquete, José J. Pérez, Patryk Krzemiński, Noemí Puig, María‐Victoria Mateos, Ramón García‐Sánz, Ana B. Herrero, Norma C. Gutiérrez	25
7	Health Insurance and the Use of Peritoneal Dialysis in the United States 2017 ·American Journal of Kidney Diseases ·José J. Pérez, Bo Zhao, (unknown), Wolfgang C. Winkelmayer, Kevin F. Erickson	19
8	PD-1 and PD-L1 Are Overexpressed in the "Intermediate CD14+CD16+" and "Non Classical CD14lowCD16+" but Not in the "Classical CD14+CD16-" Monocytes in the Peripheral Blood of Chronic Myelomonocytic Leukemia 2015 ·Blood ·Hae Tha Mya, María Díez‐Campelo, (unknown), Agustín Díaz-Álvarez, (unknown), (unknown), José J. Pérez, Verónica González‐Calle, José María Bastida, Carlos Aguilar, Abelardo Bárez, Noemí Puig, Alejandro Martı́n, (unknown), (unknown), Sara Alonso, Marcos González, Consuelo del Cañizo, María‐Belén Vídriales	1
9	COMPARACIÓN ENTRE ELECTRODOS POSAI Y ELECTRODOS COMERCIALES EN LA TITULACIÓN POTENCIOMÉTRICA DE SULFAMETOXAZOL Y TRIMETOPRIMA 2012 ·SHILAP Revista de lepidopterología ·Graciela Romero, (unknown), (unknown), José J. Pérez, (unknown), (unknown)	0
10	The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis 2011 ·Blood ·Bruno Paiva, María‐Belén Vídriales, José J. Pérez, (unknown), Ramón García‐Sánz, Enrique M. Ocio, Natalia de las Heras, Rebeca Cuello, Alfonso García de Coca, Emilia Pardal, José María Alonso, Magdalena Sierra, Abelardo Bárez, José‐Ángel Hernández‐Rivas, (unknown), Josefina Galende, María‐Victoria Mateos, Jesús F. San Miguel	46
11	Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients 2009 ·Haematologica ·Bruno Paiva, María‐Belén Vídriales, José J. Pérez, Gema Mateo, María Ángeles Montalbán, María‐Victoria Mateos, Joan Bladé, Juan José Lahuerta, (unknown), Jesús F. San Miguel	65
12	Minimal residual disease monitoring after allogeneic transplantation may help to individualize post‐transplant therapeutic strategies in acute myeloid malignancies 2008 ·American Journal of Hematology ·María Díez‐Campelo, Josè Antonio Pérez-Simón, José J. Pérez, Miguel Alcoceba, (unknown), María‐Belén Vídriales, Jesús F. San Miguel	38
13	Molecular Characterization of Complete and Incomplete Immunoglobulin Heavy Chain Gene Rearrangements in Hairy Cell Leukemia 2007 ·Clinical Lymphoma & Myeloma ·Patricia Martín‐Jiménez, Ramón García‐Sánz, David González, Ana Balanzategui, José J. Pérez, Marı́a Dolores Caballero, María Eugenia Sarasquete, Josefina Galende, Alberto Órfão, M C López-Berges, Jesús F. San Miguel, Marcos González	7
14	Functional class switch recombination may occur ‘in vivo’ in Waldenström macroglobulinaemia 2006 ·British Journal of Haematology ·Patricia Martín‐Jiménez, Ramón García‐Sánz, María Eugenia Sarasquete, Enrique M. Ocio, José J. Pérez, Marcos González, Jesús F. San Miguel	11
15	Geographic differences in the incidence of cytogenetic abnormalities of acute myelogenous leukemia (AML) in Spain 2006 ·Leukemia Research ·Magdalena Sierra, Álvaro Alonso, María D. Odero, Montserrat González, (unknown), José J. Pérez, Juan Luis Garcı́a, Norma C. Gutiérrez, Marı́a José Calasanz, Jesús F. San Miguel, Jesús María Hernández‐Rivas	17
16	Hematological, immunophenotypic, and cytogenetic characteristics of acute myeloblastic leukemia with trisomy 11 2005 ·Cancer Genetics and Cytogenetics ·Magdalena Sierra, Jesús María Hernández‐Rivas, Juan Luis Garcı́a, Norma C. Gutiérrez, José J. Pérez, María‐Belén Vídriales, Fernando Ramos, José M. Hernández, (unknown), Montserrat González, Josefina Galende, Jesús F. San Miguel	6
17	Genetic heterogeneity of BCR/ABL+ adult B-cell precursor acute lymphoblastic leukemia: impact on the clinical, biological and immunophenotypical disease characteristics 2005 ·Leukemia ·(unknown), María Dolores Tabernero, José J. Pérez, Ana Rasillo, José María Sayagués, Ana Espinosa, M C López-Berges, Ramón García‐Sánz, Norma C. Gutiérrez, Jesús María Hernández‐Rivas, (unknown), (unknown), M Giralt, (unknown), Jesús F. San Miguel, (unknown)	28
18	Interference excision algorithm for frequency hopping spread spectrum based on undecimated wavelet packet transform 2002 ·Electronics Letters ·José J. Pérez, Miguel A. Rodríguez-Hernández, Santiago Felici-Castell	3
19	Usefulness of the rearrangement of the bcr/abl gene in extramedullary (lymph nodes) blast crisis diagnosed in chronic myeloid leukaemia 1993 ·British Journal of Haematology ·Fernando A. González, Augusto Villegas, Maria Teresa Ferrò, P. de Paz, Domingo Morales, José J. Pérez, (unknown)	8
20	[Hematologic significance of erythrocytic macrocytosis: prospective analysis of 109 successively studied cases]. 1989 ·PubMed ·José J. Pérez, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact